FK506 Treatment Prevents Retinal Nerve Fiber Layer Thinning in Organ-Transplanted Glaucoma Patients: A Retrospective Longitudinal Study

Purpose This is a retrospective study of primary open-angle glaucoma patients treated with the immunosuppressor FK506 (tacrolimus) after an organ transplant. We assessed whether FK506 might be a potential neuroprotector adjuvant in glaucoma therapy. Patients and methods Organ transplant patients tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Reffatto, Valentina, Gupta, Praveena K, Williams, Tamila, Schmitz-Brown, Mary E, Vizzeri, Gianmarco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544622/
https://www.ncbi.nlm.nih.gov/pubmed/34722017
http://dx.doi.org/10.7759/cureus.18192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544622/
https://www.ncbi.nlm.nih.gov/pubmed/34722017
http://dx.doi.org/10.7759/cureus.18192

Ejemplares similares